临床PI
嵇庆海 教授
教授,博士生导师
E-mail: jiqinghai@shca.org.cn
 

  1983年毕业于上海医科大学获临床医学学士学位,1993年获上海医科大学临床医学硕士学位,2002年晋升为主任医师。从事头颈部肿瘤外科33年,擅长于甲状腺癌、喉癌、下咽癌及舌癌的临床及基础研究。现任复旦大学附属肿瘤医院头颈外科主任、复旦大学附属肿瘤医院头颈部肿瘤多学科综合治疗组首席专家、中国抗癌协会甲状腺癌专业委员会副主任委员、中国医师协会甲状腺癌专业委员会副主任委员、上海抗癌协会甲状腺癌专业委员会主任委员、上海医学会普外科专业委员会甲状腺学组组长、中国抗癌协会头颈肿瘤专业委员会常委、上海抗癌协会头颈肿瘤专业委员会前任主任委员、意大利内分泌外科协会荣誉会员,担任《中华耳鼻咽喉---头颈外科杂志》、《中华外科杂志》、《中华肿瘤杂志》、《中国医学科学院学报》、《肿瘤》、《中国癌症杂志》、《Chinese Medical Journal》、《Medicine》、《World Journal of Surgical Oncology》及《Oncotargets and Therapy》杂志编委及审稿专家。主持国家科学基金面上项目四项、上海市科委重大项目、上海市基础研究重大项目及上海市重中之重项目多项,参与编写《肿瘤外科手术学》,沈镇宙主编,江苏科学技术出版社;《现代肿瘤学》,汤钊猷主编,复旦大学出版社;《外科学》七年制教材,陈孝平主编,人民卫生出版社;《口腔颌面头颈部肿瘤生物学》,陈万涛主编,上海交通大学出版社;发表论文50余篇,其中SCI收录30余篇,国内权威期刊10余篇。


研究领域:

  1.专业特长:头颈部肿瘤外科、甲状腺、 唾液腺、口腔肿瘤、喉癌及喉咽癌的诊断和手术治疗。
  2.科研方向:头颈部肿瘤及甲状腺癌的基础及临床研究。

研究队伍:



代表性论著:

  1. Shi RL#, Qu N#, Liao T#, Wang YL, Wang Y, Sun GH, Ji QH*. Expression, clinical significance and mechanism of Slit2 in papillary thyroid cancer. Int J Oncol, 2016 May; 48(5):2055-62.
  2. Qu N#,Shi RL#, Ma B, Gao Y, Wang Y, Ji QH*. The Prediction of Sonographic features and BRAF Mutation for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Reply. World Journal of Surgery, 2016 Mar; 40(3):761-3.
  3. Shi RL#, Liao T#, Qu N#,Liang F, Chen JY, Ji QH*. The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma. Otolaryngology - Head and Neck Surgery, 2016 Feb; 154(2):256-62.
  4. Qu N#, Shi RL#, Luo TX#, Wang YL, Li DS, Wang Y, Huang CP, Ji QH*. Prognostic significance and optimal cutoff of age in medullary thyroid cancer. Oncotarget, 2016 Mar 29; 7(13):15937-47. 
  5. Shi RL#, Qu N#, Liao T#, Wei WJ, Lu ZW, Ma B, Wang YL, Ji QH*. Relationship of body mass index with BRAF V600E mutation in papillary thyroid cancer. TumourBiol, 2016 Jun; 37(6):8383-90.
  6. Qu N#, Zhang L#, Lu ZW#, Ji QH*, Yang SW, Wei WJ, Zhang Y. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature. Tumor Biology, 2016 Jun; 37(6):7797-808. 
  7. Qu N#,Zhang L#,Lin DZ#, Ji QH*, Zhu YX, Wang Y. The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma. Tumor Biology, 2016 Jun; 37(6):7685-92.
  8. Gao Y#, Qu N#,Zhang L#,Chen JY, Ji QH*. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma. Tumor Biology, 2016 Jun; 37(6):7453-9.
  9. Qu N#, Zhang L#, Ji QH*, Chen JY, Zhu YX, Cao YM, Shen Q. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis. World Journal of Surgery, 2015 Oct; 39(10):2459-70.
  10. Wang YL, Sun JG, Wang J, Wei WJ, Zhu YX, Wang Y, Sun GH, Xu K, Li H, Zhang L, Ji QH*. Schwannoma of the cervical esophagus: Report of 2 cases and a review of the literature. Ear Nose Throat J, 2015 Sep; 94(9):E10-3.
  11. Wei WJ, Wang YL, Li DS, Wang Y, Wang XF, Zhu YX, Pan XD, Wang ZY, Wu Y, Jin L, Wang JC, Ji QH*. Association study of single nucleotide polymorphisms in mature microRNAs and the risk of thyroid tumor in a Chinese population. Endocrine,2015 Jun; 49(2):436-44.
  12. Wei WJ#, Lu ZW#, Wang Y, Zhu YX, Wang YL, Ji QH*. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies. Cancer Genet, 2015 Mar; 208(3):68-75.
  13. Wei WJ#, Lu ZW#, Li DS, Wang Y, Zhu YX, Wang ZY, Wu Y, Wang YL, Ji QH*. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population. Int J MolSci, 2014 Nov 14; 15(11):20968-81.
  14. Qu N#, Zhang L#, Lu ZW#, Wei WJ, Zhang Y, Ji QH*. Risk of malignancy in focal thyroid lesions identified by (18)F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies. Tumour Biol, 2014 Jun; 35(6):6139-47. 
  15. Qu N#, Zhang L#, Ji QH*, Zhu YX, Wang ZY, Shen Q, Wang Y, Li DS. Number of tumor foci predicts prognosis in papillary thyroid cancer. BMC Cancer, 2014 Dec 4; 14:914.
  16. Wang YL, Li DS, Wang Y, Wang ZY, Ji QH*. Lymph node ratio for postoperative staging of laryngeal squamous cell carcinoma with lymph node metastasis. PLoS One, 2014 Jan 27; 9(1):e87037.
  17. Wang YL#, Feng SH#, Guo SC#, Wei WJ, Li DS, Wang Y, Wang XF, Wang ZY, Ma YY, Jin L, Ji QH, Wang JC*. Confirmation of papillary thyroid cancer susceptibilityloci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35and 8p12 inaChinese population. J Med Genet, 2013 Oct; 50(10):689-95.
  18. Wei WJ#, Wang YL# , Li DS#, Wang Y, Wang XF, Zhu YX, Yang YJ, Wang ZY, MaYY, Wu Y, Jin L, Ji QH, Wang JC*.Association between thers2910164 Polymorphism in Pre-Mir-146aSequence and Thyroid Carcinogenesis. PLoS One, 2013; 8(2):e56638.
  19. Zhang L#, Li H#, Ji QH#, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y*. The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer, 2012 Dec 21; 12:610.
  20. Wang YL#, Zhu YX#, Chen TZ#, Wang Y, Sun GH, Zhang L, Huang CP, Wang ZY, Shen Q, Li DS, Wu Y, Ji QH*. Clinicopathologic study of 1176 salivary gland tumors in a Chinese population: experience of one cancer center 1997-2007. Acta Otolaryngol, 2012 Aug; 132(8):879-86.
  21. Zhang L#, Wei WJ#, Ji QH#, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y.Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab, 2012 Apr; 97(4):1250-7.
  22. Zhang L, Zhu YX, Wang Y, Huang CP, Wu Y, Ji QH*.Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience. Ann Surg Oncol, 2011 Jan; 18(1):233-8.
  23. Wang YL, Wang JC, Wu Y, Zhang L, Huang CP, Shen Q, Zhu YX, Li DS, Ji QH*. Incidentally simultaneous occurrence of RET/PTC, H4-PTEN and BRAF mutation in papillary thyroid carcinoma. Cancer Lett, 2008 May 8; 263(1):44-52.
 
复旦大学肿瘤研究所 通讯地址: 东安路270号2号楼1312室 64175590-5312 Email:fuci2012@126.com
Copyright 2013 shca.org.cn All rights reserved. 复旦大学肿瘤研究所 版权所有